Macrophage Functions in Psoriasis: Lessons from Mouse Models

Psoriasis is a systemic autoimmune/autoinflammatory disease that can be well studied in established mouse models. Skin-resident macrophages are classified into epidermal Langerhans cells and dermal macrophages and are involved in innate immunity, orchestration of adaptive immunity, and maintenance of tissue homeostasis due to their ability to constantly shift their phenotype and adapt to the current microenvironment. Consequently, both macrophage populations play dual roles in psoriasis. In some circumstances, pro-inflammatory activated macrophages and Langerhans cells trigger psoriatic inflammation, while in other cases their anti-inflammatory stimulation results in amelioration of the disease. These features make macrophages interesting candidates for modern therapeutic strategies. Owing to the significant progress in knowledge, our review article summarizes current achievements and indicates future research directions to better understand the function of macrophages in psoriasis.

[1]  I. Aljuffali,et al.  RNA-Based Antipsoriatic Gene Therapy: An Updated Review Focusing on Evidence from Animal Models , 2024, Drug design, development and therapy.

[2]  Zhengwei Zou,et al.  MAPK14 as a key gene for regulating inflammatory response and macrophage M1 polarization induced by ferroptotic keratinocyte in psoriasis. , 2024, Inflammation.

[3]  Y. Zhen,et al.  Pentraxin 3 exacerbates psoriasiform dermatitis through regulation of macrophage polarization. , 2024, International immunopharmacology.

[4]  C. Jonak,et al.  Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα , 2024, Dermatology and therapy.

[5]  Haoting Li,et al.  A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation , 2024, Nature communications.

[6]  Chwan-Fwu Lin,et al.  The anti‐inflammatory activity of flavonoids and alkaloids from Sophora flavescens alleviates psoriasiform lesions: Prenylation and methoxylation beneficially enhance bioactivity and skin targeting , 2024, Phytotherapy research : PTR.

[7]  Marcarious M. Tantuoyir,et al.  Exploring the polarization of M1 and M2 macrophages in the context of skin diseases. , 2024, Molecular biology reports.

[8]  A. Alvarado-Navarro,et al.  Etiopathogenesis of Psoriasis: Integration of Proposed Theories , 2024, Immunological investigations.

[9]  Wanying Lan,et al.  The roles of tissue resident macrophages in health and cancer , 2024, Experimental hematology & oncology.

[10]  A. Gombart,et al.  Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis , 2024, The Journal of clinical investigation.

[11]  Zongguang Tai,et al.  Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets , 2024, Frontiers in immunology.

[12]  Haitao Li,et al.  Yogurt Alleviates Imiquimod-Induced Psoriasis by Activating the Lactate/GPR81 Signaling Axis in Mice. , 2024, Journal of agricultural and food chemistry.

[13]  Xiaoli Min,et al.  Keratinocyte-to-macrophage communication exacerbate psoriasiform dermatitis via LRG1-enriched extracellular vesicles , 2024, Theranostics.

[14]  Yuying Jia,et al.  Identification of ADAM23 as a Potential Signature for Psoriasis Using Integrative Machine-Learning and Experimental Verification , 2023, International journal of general medicine.

[15]  Yujun Song,et al.  A Nanoinhibitor Targeting cGAS-STING Pathway to Reverse the Homeostatic Imbalance of Inflammation in Psoriasis. , 2023, Angewandte Chemie.

[16]  Y. Yanase,et al.  Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching , 2023, Frontiers in immunology.

[17]  Qian Zhang,et al.  Advances in the study of macrophage polarization in inflammatory immune skin diseases , 2023, Journal of Inflammation.

[18]  Jing Chen,et al.  Keratinocyte derived HMGB1 aggravates psoriasis dermatitis via facilitating inflammatory polarization of macrophages and hyperproliferation of keratinocyte. , 2023, Molecular immunology.

[19]  Weiwei Chen,et al.  Stress aggravates imiquimod-induced psoriasiform inflammation by promoting M1 macrophage polarization. , 2023, International immunopharmacology.

[20]  S. Künzel,et al.  Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis , 2023, The Journal of pathology.

[21]  Yan Wang,et al.  Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Mouse Model via Reducing Macrophage Infiltration and Inhibiting Glycolysis , 2023, Journal of inflammation research.

[22]  K. Bryniarski,et al.  Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared? , 2023, Frontiers in Cell and Developmental Biology.

[23]  Zengyang Yu,et al.  The role of microRNA in psoriasis: A review , 2023, Experimental dermatology.

[24]  Luxian Zhou,et al.  Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation , 2023, The Journal of dermatological treatment.

[25]  S. Motegi,et al.  TRPV4 regulates the development of psoriasis by controlling ATP expression in keratinocytes and the neuroimmune system. , 2023, The Journal of investigative dermatology.

[26]  Shiyu Hu,et al.  The macrophage polarization in inflammatory dermatosis and its potential drug candidates. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  R. Tan,et al.  Macrophages mediate psoriasis via Mincle-dependent mechanism in mice , 2023, Cell death discovery.

[28]  Yi Cao,et al.  Study of dietary‑induced progression of psoriasis‑like mice based on gut macrophage polarization , 2023, Experimental and therapeutic medicine.

[29]  B. Chiang,et al.  M2‐like macrophages polarized by Foxp3− Treg‐of‐B cells ameliorate imiquimod‐induced psoriasis , 2023, Journal of cellular and molecular medicine.

[30]  T. Powell-Wiley,et al.  Comparison of the dietary omega-3 fatty acids impact on murine psoriasis-like skin inflammation and associated lipid dysfunction. , 2023, The Journal of nutritional biochemistry.

[31]  Fu-Tong Liu,et al.  PD-L1 Enhanced by cis-Urocanic Acid on Langerhans Cells Inhibits Vγ4+ γδT17 Cells in Psoriatic Skin Inflammation. , 2023, The Journal of investigative dermatology.

[32]  Kutty Selva Nandakumar,et al.  Comparative studies on mannan and imiquimod induced experimental plaque psoriasis inflammation in inbred mice , 2023, Clinical and experimental immunology.

[33]  X. Fan,et al.  Inhibition of serum and glucocorticoid-regulated protein kinase-1 aggravates imiquimod-induced psoriatic dermatitis and enhances proinflammatory cytokine expression via the NF-kappaB pathway. , 2023, The Journal of investigative dermatology.

[34]  K. Safranow,et al.  Adiponectin, Leptin and Resistin in Patients with Psoriasis , 2023, Journal of clinical medicine.

[35]  Wang Hee Lee,et al.  Hyaluronic Acid Nanoparticles as a Topical Agent for Treating Psoriasis. , 2022, ACS nano.

[36]  P. Lio,et al.  Biologics and Small Molecule Inhibitors: an Update in Therapies for Allergic and Immunologic Skin Diseases , 2022, Current Allergy and Asthma Reports.

[37]  Weiguo Sun,et al.  Etanercept alleviates psoriasis by reducing the Th17/Treg ratio and promoting M2 polarization of macrophages , 2022, Immunity, inflammation and disease.

[38]  K. Khosrotehrani,et al.  Macrophages in Skin Wounds: Functions and Therapeutic Potential , 2022, Biomolecules.

[39]  Adam Wroński,et al.  Impact of ROS-Dependent Lipid Metabolism on Psoriasis Pathophysiology , 2022, International journal of molecular sciences.

[40]  A. Regev,et al.  Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling. , 2022, Immunity.

[41]  L. Macia,et al.  Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development. , 2022, Cell reports.

[42]  N. Okiyama,et al.  The role of programmed cell death ligand-1 on Langerhans cells in the regulation of psoriasis. , 2022, The Journal of investigative dermatology.

[43]  M. Winnefeld,et al.  Macrophages are polarized towards an inflammatory phenotype by their aged microenvironment in the human skin. , 2022, The Journal of investigative dermatology.

[44]  Valmore Bermúdez,et al.  Exploring the Links between Obesity and Psoriasis: A Comprehensive Review , 2022, International journal of molecular sciences.

[45]  Y. Tada,et al.  Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis , 2022, Frontiers in Immunology.

[46]  A. Lusis,et al.  Oxy210, a Semi-Synthetic Oxysterol, Exerts Anti-Inflammatory Effects in Macrophages via Inhibition of Toll-like Receptor (TLR) 4 and TLR2 Signaling and Modulation of Macrophage Polarization , 2022, International journal of molecular sciences.

[47]  Xushan Cha,et al.  Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis , 2022, Bioengineered.

[48]  K. Sugiura Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond , 2022, Dermatology and Therapy.

[49]  Kan Ze,et al.  Celastrol gel ameliorates imiquimod-induced psoriasis-like dermatitis in mice by targeting Langerhans cells. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  Nicoleta Anton,et al.  Update on the etiopathogenesis of psoriasis (Review) , 2022, Experimental and therapeutic medicine.

[51]  Mengyao Wang,et al.  The Role of Helper T Cells in Psoriasis , 2021, Frontiers in Immunology.

[52]  J. Gudjonsson,et al.  Mouse Models of Psoriasis: A Comprehensive Review. , 2021, The Journal of investigative dermatology.

[53]  Yajing Gao,et al.  Hsa_circ_0004287 inhibits macrophage-mediated inflammation in an N6-methyladenosine-dependent manner in atopic dermatitis and psoriasis. , 2021, The Journal of allergy and clinical immunology.

[54]  Nitwara Wikan,et al.  Anti-psoriatic and anti-inflammatory effects of Kaempferia parviflora in keratinocytes and macrophage cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[55]  Ling-juan Zhang,et al.  Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity , 2021, JID innovations.

[56]  K. Nakai,et al.  What Are Reactive Oxygen Species, Free Radicals, and Oxidative Stress in Skin Diseases? , 2021, International journal of molecular sciences.

[57]  Yi Zhao,et al.  Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation. , 2021, Immunity.

[58]  G. Novelli,et al.  Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis , 2021, Genes.

[59]  D. Kang,et al.  Mitochondrial Reactive Oxygen Species Are Essential for the Development of Psoriatic Inflammation , 2021, Frontiers in Immunology.

[60]  F. Sánchez‐Madrid,et al.  Antibodies Enhance the Suppressive Activity of Extracellular Vesicles in Mouse Delayed-Type Hypersensitivity , 2021, Pharmaceuticals.

[61]  Chun-Ming Huang,et al.  Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis , 2021, Pharmaceutics.

[62]  Johannes U. Mayer,et al.  Fate mapping analysis reveals a novel murine dermal migratory Langerhans-like cell population , 2021, eLife.

[63]  N. Rosenthal,et al.  Macrophages in dermatology: pathogenic roles and targeted therapeutics , 2021, Archives of Dermatological Research.

[64]  E. Kerzberg,et al.  Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis , 2021, Frontiers in Immunology.

[65]  E. Muñoz-Elías,et al.  Differential Changes in Inflammatory Mononuclear Phagocyte and T Cell Profiles within Psoriatic Skin during Treatment with Guselkumab versus Secukinumab. , 2021, The Journal of investigative dermatology.

[66]  S. Teichmann,et al.  Developmental cell programs are co-opted in inflammatory skin disease , 2021, Science.

[67]  Xiang Chen,et al.  The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis , 2020, Journal of cellular and molecular medicine.

[68]  P. Askenase,et al.  Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains , 2020, International journal of molecular sciences.

[69]  L. Macia,et al.  Immune Modulation of Monocytes Dampens the IL-17+ γδ T cell Response and Associated Psoriasis Pathology in Mice. , 2020, The Journal of investigative dermatology.

[70]  I. Iskandar,et al.  Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender * , 2020, The British journal of dermatology.

[71]  N. Sweiss,et al.  TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin‐to‐joint crosstalk in psoriatic arthritis , 2020, European Journal of Immunology.

[72]  L. Carvalho,et al.  Mononuclear Phagocyte Activation Is Associated With the Immunopathology of Psoriasis , 2020, Frontiers in Immunology.

[73]  A. Kerstan,et al.  Current Developments in the Immunology of Psoriasis , 2020, The Yale journal of biology and medicine.

[74]  Y. J. Kang,et al.  4-1BBL Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis , 2020, The Journal of Immunology.

[75]  Hong-Yu Zhang,et al.  PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. , 2019, Life sciences.

[76]  Wei Wei,et al.  Murine models of psoriasis and its applications in drug development. , 2019, Journal of pharmacological and toxicological methods.

[77]  F. Sánchez‐Madrid,et al.  Syngeneic red blood cell–induced extracellular vesicles suppress delayed‐type hypersensitivity to self‐antigens in mice , 2019, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[78]  C. Dinarello,et al.  The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis , 2019, International journal of molecular sciences.

[79]  B. Gibbs,et al.  Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases , 2019, Front. Immunol..

[80]  J. Farber,et al.  IL‐23‐ and Imiquimod‐Induced Models of Experimental Psoriasis in Mice , 2019, Current protocols in immunology.

[81]  P. Askenase,et al.  Delayed-Type Hypersensitivity Underlying Casein Allergy Is Suppressed by Extracellular Vesicles Carrying miRNA-150 , 2019, Nutrients.

[82]  S. Gauld,et al.  Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation , 2019, Scientific Reports.

[83]  Adriana Rendon,et al.  Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.

[84]  Mayuko Yamamoto,et al.  Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production. , 2019, Journal of dermatological science.

[85]  Sungwon Jung,et al.  Decreased expression of response gene to complement 32 in psoriasis and its association with reduced M2 macrophage polarization , 2019, The Journal of dermatology.

[86]  Yu-Wen Su,et al.  Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation , 2018, Mediators of inflammation.

[87]  R. Haba,et al.  Macrophages express βKlotho in skin lesions of psoriatic patients and the skin of imiquimod‐treated mice , 2018, The Journal of dermatology.

[88]  S. Brain,et al.  Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  P. Askenase,et al.  Antibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by Exosomes , 2018, International journal of molecular sciences.

[90]  Min‐Geol Lee,et al.  Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model. , 2018, Journal of dermatological science.

[91]  Ting Liu,et al.  The Peritoneal Macrophages in Inflammatory Diseases and Abdominal Cancers. , 2018, Oncology research.

[92]  C. Griffiths,et al.  Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin‐17 , 2018, The British journal of dermatology.

[93]  Y. Sidi,et al.  The contribution of feedback loops between miRNAs, cytokines and growth factors to the pathogenesis of psoriasis , 2018, Experimental dermatology.

[94]  Maxim N. Artyomov,et al.  Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis , 2018, Nature.

[95]  J. Krueger,et al.  Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment , 2018, Therapeutic advances in chronic disease.

[96]  K. Otsu,et al.  p38α signaling in Langerhans cells promotes the development of IL-17–producing T cells and psoriasiform skin inflammation , 2018, Science Signaling.

[97]  Linnan Zhu,et al.  IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis , 2018, Protein & Cell.

[98]  L. Eidsmo,et al.  Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions , 2018, Front. Immunol..

[99]  S. Jalkanen,et al.  The Macrophage Mannose Receptor Regulate Mannan-Induced Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis-Like Disease Models , 2018, Front. Immunol..

[100]  H. Hammad,et al.  Langerhans Cells: Sensing the Environment in Health and Disease , 2018, Front. Immunol..

[101]  G. Farronato,et al.  Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? , 2018, Journal of immunology research.

[102]  A. Paun,et al.  Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment , 2018, The Journal of experimental medicine.

[103]  L. Tsoi,et al.  Psoriasis: a mixed autoimmune and autoinflammatory disease. , 2017, Current opinion in immunology.

[104]  A. Vallejo,et al.  Langerhans Cells—Programmed by the Epidermis , 2017, Front. Immunol..

[105]  Marta Moskot,et al.  Models in the Research Process of Psoriasis , 2017, International journal of molecular sciences.

[106]  R. Pouliot,et al.  Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis , 2017, Mediators of inflammation.

[107]  T. Tsai,et al.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness , 2017, Therapeutic advances in musculoskeletal disease.

[108]  W. Lambert,et al.  Langerhans cell: exciting developments in health and disease , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[109]  K. Nagao,et al.  Langerhans Cells - The Macrophage in Dendritic Cell Clothing. , 2017, Trends in immunology.

[110]  R. Haba,et al.  IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice , 2017, Scientific Reports.

[111]  D. Kaplan Ontogeny and function of murine epidermal Langerhans cells , 2017, Nature Immunology.

[112]  T. Dainichi,et al.  Inhibition of IL‐17–committed T cells in a murine psoriasis model by a vitamin D analogue , 2017, The Journal of allergy and clinical immunology.

[113]  C. Xiao,et al.  Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis. , 2017, Journal of dermatological science.

[114]  O. Colegio,et al.  The role of macrophages in skin homeostasis , 2017, Pflügers Archiv - European Journal of Physiology.

[115]  S. Ludwig,et al.  Macrophage‐mediated psoriasis can be suppressed by regulatory T lymphocytes , 2016, The Journal of pathology.

[116]  D. M. Elizondo,et al.  Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor , 2016, Journal of leukocyte biology.

[117]  Yuquan Wei,et al.  IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis , 2016, The Journal of Immunology.

[118]  R. Sabat,et al.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations , 2016, Reviews in Endocrine and Metabolic Disorders.

[119]  J. Rossjohn,et al.  CD1a on Langerhans cells controls inflammatory skin diseases , 2016, Nature Immunology.

[120]  Maxim N. Artyomov,et al.  Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. , 2016, Cell metabolism.

[121]  Shinichi Sato,et al.  CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. , 2016, Journal of dermatological science.

[122]  F. Akın,et al.  Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris , 2016, Annals of dermatology.

[123]  F. Ginhoux,et al.  New insights into the multidimensional concept of macrophage ontogeny, activation and function , 2015, Nature Immunology.

[124]  M. Bajénoff,et al.  Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis , 2015, The Journal of Immunology.

[125]  P. Askenase,et al.  Macrophages play an essential role in antigen‐specific immune suppression mediated by T CD8+ cell‐derived exosomes , 2015, Immunology.

[126]  Delphine J. Lee,et al.  Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease , 2015, The Journal of Immunology.

[127]  M. Sanak,et al.  Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells , 2015, PloS one.

[128]  Kutty Selva Nandakumar,et al.  Reactive Oxygen Species in Psoriasis and Psoriasis Arthritis: Relevance to Human Disease , 2015, International Archives of Allergy and Immunology.

[129]  F. Geissmann,et al.  Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.

[130]  R. Holmdahl,et al.  Mannan induces ROS-regulated, IL-17A–dependent psoriasis arthritis-like disease in mice , 2014, Proceedings of the National Academy of Sciences.

[131]  F. Aubin,et al.  Relationships between Adipose Tissue and Psoriasis, with or without Arthritis , 2014, Front. Immunol..

[132]  B. Malissen,et al.  IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. , 2014, The Journal of investigative dermatology.

[133]  C. Putterman,et al.  Targeting TNF and Its Family Members in Autoimmune/Inflammatory Disease , 2014, Mediators of inflammation.

[134]  Hyung-ran Kim,et al.  Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function , 2014, PloS one.

[135]  Yuquan Wei,et al.  IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production , 2014, The Journal of Immunology.

[136]  B. Malissen,et al.  Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. , 2013, Immunity.

[137]  Dong Yu,et al.  A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis. , 2013, The Journal of investigative dermatology.

[138]  Jun Lu,et al.  Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. , 2013, The Journal of allergy and clinical immunology.

[139]  P. Filipe,et al.  Mechanisms of Action of Topical Corticosteroids in Psoriasis , 2012, International journal of endocrinology.

[140]  Xiaoxia Zhu,et al.  Adipokines in Psoriatic Arthritis Patients: The Correlations with Osteoclast Precursors and Bone Erosions , 2012, PloS one.

[141]  R. Feil,et al.  Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells , 2011, The Journal of experimental medicine.

[142]  U. Mrowietz,et al.  Oxidative stress in the pathogenesis of psoriasis. , 2009, Free radical biology & medicine.

[143]  N. Yawalkar,et al.  Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. , 2009, Journal of dermatological science.

[144]  D. Diaconu,et al.  Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis. , 2009, The American journal of pathology.

[145]  M. Pasparakis,et al.  Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. , 2006, The Journal of clinical investigation.

[146]  N. Van Rooijen,et al.  Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. , 2006, The Journal of clinical investigation.

[147]  R. Clark,et al.  Misbehaving macrophages in the pathogenesis of psoriasis. , 2006, The Journal of clinical investigation.

[148]  A. Menssen,et al.  T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.

[149]  W. Jochum,et al.  T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.

[150]  K. Ghoreschi,et al.  Recent advances in understanding psoriasis , 2022 .